| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-18541-25ul | |||
| Azide and BSA Free | NBP3-44380 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-48954-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-38434-25ul | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| FITC | NBP1-73845-10mg | |||
| HRP | NBP1-73847-10mg | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| FITC | NBP1-97202 | |||
| HRP | NBP1-97203 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47908-0.1mg | |||
![Immunohistochemistry-Paraffin: CD30/TNFRSF8 Antibody (CL12632) [NBP3-18541] - Staining of human tonsil shows moderate membranous positivity in germinal center cells.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-CL12632-Immunohistochemistry-Paraffin-NBP3-18541-img0003.jpg "Immunohistochemistry-Paraffin: CD30/TNFRSF8 Antibody (CL12632) [NBP3-18541] - Staining of human tonsil shows moderate membranous positivity in germinal center cells.")
![Immunohistochemistry-Paraffin: CD30/TNFRSF8 Antibody (CL12632) [NBP3-18541] - Staining of human testis cancer (embryonal carcinoma) shows moderate membranous positivity in tumor cells.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-CL12632-Immunohistochemistry-Paraffin-NBP3-18541-img0001.jpg)
![Immunohistochemistry-Paraffin: CD30/TNFRSF8 Antibody (CL12632) [NBP3-18541] - Staining of human ovarian cancer (dysgeminoma) shows moderate membranous positivity in tumor cells.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-CL12632-Immunohistochemistry-Paraffin-NBP3-18541-img0002.jpg)
![Immunohistochemistry-Paraffin: CD30/TNFRSF8 Antibody (CL12632) [NBP3-18541] - Staining of human testis shows weak membranous and cytoplasmic positivity in cells in seminiferous ducts.](http://images.novusbio.com/fullsize/CD30-TNFRSF8-Antibody-CL12632-Immunohistochemistry-Paraffin-NBP3-18541-img0004.jpg)
![Immunohistochemistry-Paraffin: B7-1/CD80 Antibody [NBP2-48954] - Staining in human tonsil and pancreas tissues using anti-CD80 antibody. Corresponding CD80 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-Immunohistochemistry-Paraffin-NBP2-48954-img0005.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: B7-1/CD80 Antibody [NBP2-48954] - Staining in human tonsil and pancreas tissues using anti-CD80 antibody. Corresponding CD80 RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: B7-1/CD80 Antibody [NBP2-48954] - Staining of human tonsil shows high expression.](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-Immunohistochemistry-Paraffin-NBP2-48954-img0004.jpg)
![Immunohistochemistry-Paraffin: B7-1/CD80 Antibody [NBP2-48954] - Staining of human pancreas shows low expression as expected.](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-Immunohistochemistry-Paraffin-NBP2-48954-img0003.jpg)
![Western Blot: CD27/TNFRSF7 Antibody [NBP2-38434] - Lane 1: Marker [kDa] 250, 130, 100, 70, 55, 35, 25, 15, 10<br/>Lane 2: Human cell line Daudi](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-Western-Blot-NBP2-38434-img0002.jpg "Western Blot: CD27/TNFRSF7 Antibody [NBP2-38434] - Lane 1: Marker [kDa] 250, 130, 100, 70, 55, 35, 25, 15, 10<br/>Lane 2: Human cell line Daudi")
![Immunohistochemistry: CD20 Antibody (PD00-02) [NBP3-32131] - Immunohistochemical analysis of paraffin-embedded human tonsil tissue with Rabbit anti-CD20 antibody (NBP3-32131) at 1/2,000 dilution.<br/><br/> The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (NBP3-32131) at 1/2,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.](http://images.novusbio.com/fullsize/nbp3-32131_rabbit-cd20-mab-pd00-02-29820241435213.jpg "Immunohistochemistry: CD20 Antibody (PD00-02) [NBP3-32131] - Immunohistochemical analysis of paraffin-embedded human tonsil tissue with Rabbit anti-CD20 antibody (NBP3-32131) at 1/2,000 dilution.<br/><br/> The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (NBP3-32131) at 1/2,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.")
![Western blot analysis on different lysates with NBP3-32131 at 1/2,000 dilution. Lane 1: Raji cell lysate Lane 2: 293T cell lysate (negative) Lane 3: Ramos cell lysate Lane 4: HeLa cell lysate (negative) Lane 5: Daudi cell lysate Lysates/proteins at 20 µg/Lane. Predicted band size: 33 kDa Observed band size: 33 kDa Exposure time: 4 seconds; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. NBP3-32131 at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG [HRP] Secondary Antibody at 1/50,000 dilution was used for 1 hour at room temperature.](http://images.novusbio.com/fullsize/nbp3-32131_-western-blot-639204594549772645.jpg)
![Flow Cytometry: Siglec-2/CD22 Antibody (RFB4) [NBP2-49890] - Flow Cytometry using Siglec-2/CD22 Antibody (RFB4).](http://images.novusbio.com/fullsize/Siglec-2-CD22-Antibody-RFB4-Flow-Cytometry-NBP2-49890-img0001.jpg "Flow Cytometry: Siglec-2/CD22 Antibody (RFB4) [NBP2-49890] - Flow Cytometry using Siglec-2/CD22 Antibody (RFB4).")
![SDS-Page: Rat IgM Isotype Control [NBP1-96776] - Lane M: 3 uL Opal Prestained Marker. Lane 1: Reduced Rat IgG Whole Molecule. Lane 2: Reduced Rat IgG F(c) Fragment. Lane 3: Reduced Rat IgG Fab Fragment. Lane 4: Reduced Rat IgM Whole Molecule. Load: 1 ug of IgG, F(c), Fab; 1.5 ug of IgM.](http://images.novusbio.com/fullsize/Rat-IgM-Isotype-Control-SDS-Page-NBP1-96776-img0001.jpg "SDS-Page: Rat IgM Isotype Control [NBP1-96776] - Lane M: 3 uL Opal Prestained Marker. Lane 1: Reduced Rat IgG Whole Molecule. Lane 2: Reduced Rat IgG F(c) Fragment. Lane 3: Reduced Rat IgG Fab Fragment. Lane 4: Reduced Rat IgM Whole Molecule. Load: 1 ug of IgG, F(c), Fab; 1.5 ug of IgM.")
![SDS-Page: Rat IgM Isotype Control [NBP1-96776] - Lane 1: Rat IgM, Non-Reduced. Lane 2: Rat IgM, Reduced. Load: 1.0 ug per lane.](http://images.novusbio.com/fullsize/Rat-IgM-Isotype-Control-SDS-Page-NBP1-96776-img0002.jpg)
![Flow Cytometry: MHC Class II Antibody (H42A) [NBP2-61023] - Obtained with bovine leukocytes](http://images.novusbio.com/fullsize/MHC-Class-II-Antibody-H42A-Flow-Cytometry-NBP2-61023-img0001.jpg "Flow Cytometry: MHC Class II Antibody (H42A) [NBP2-61023] - Obtained with bovine leukocytes")